The estimated Net Worth of Lisa Dombro is at least $236 Thousand dollars as of 14 September 2021. Lisa Dombro owns over 61,543 units of agilon health, inc stock worth over $235,932 and over the last 4 years Lisa sold AGL stock worth over $0.
Sign up
Lisa Dombro AGL stock SEC Form 4 insiders trading
Lisa has made over 1 trades of the agilon health, inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Lisa exercised 61,543 units of AGL stock worth $61,543 on 14 September 2021.
The largest trade Lisa's ever made was exercising 61,543 units of agilon health, inc stock on 14 September 2021 worth over $61,543. On average, Lisa trades about 30,772 units every 0 days since 2021. As of 14 September 2021 Lisa still owns at least 73,499 units of agilon health, inc stock.
You can see the complete history of Lisa Dombro stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Lisa Dombro's mailing address?
Lisa's mailing address filed with the SEC is C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH, CA, 90831.
Insiders trading at agilon health, inc
Over the last 4 years, insiders at agilon health, inc have traded over $2,766,210,380 worth of agilon health, inc stock and bought 408,814 units worth $1,411,859 . The most active insiders traders include Investment Associates Ix, L..., Veeral Desai, and Benjamin Shaker. On average, agilon health, inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,807,999. The most recent stock trade was executed by Benjamin Kornitzer on 14 March 2024, trading 5,434 units of AGL stock currently worth $17,443.
What does agilon health, inc's logo look like?
Complete history of Lisa Dombro stock trades at agilon health, inc
agilon health, inc executives and stock owners
agilon health, inc executives and other stock owners filed with the SEC include:
-
Steven Jackson Sell,
Pres, CEO & Director -
Dr. Benjamin Kornitzer M.D.,
Chief Medical & Quality Officer -
Mat Varghese,
Chief People Officer -
Ben Shaker,
Chief Markets Officer -
Claire Mulhearn,
Chief Communications & Public Affairs Officer -
Lisa Ali,
Chief Compliance Officer -
Lyn Amor Macaraeg,
VP of Legal Services -
Matthew Dale Gillmor CFA,
VP of Investor Relations -
Girish Venkatachaliah,
Chief Technology Officer -
Timothy S. Bensley,
Chief Financial Officer -
Silvana Battaglia,
Director -
Timothy Bensley,
Chief Financial Officer -
Joan Danieley,
Chief Administrative Officer -
Theodore Halkias,
Chief Business Officer -
Michelle A Gourdine,
Director -
Veeral Desai,
Chief Strategy & Dev. Officer -
Lisa Dombro,
Exper. & Innovation Officer -
Clay Richards,
Director -
Sharad Mansukani,
Director -
Benjamin Kornitzer,
Chief Med. & Quality Officer -
Benjamin Shaker,
Chief Markets Officer -
Ronald A Williams,
Director -
Glenn Sobotka,
Chief Accounting Officer -
Girish Venkatachaliah,
Chief Technology Officer -
John William Wulf,
Director -
Michael L Smith,
Director -
Karen Mc Loughlin,
Director -
Richard J Schnall,
Director -
Investment Associates Ix, L...,
-
Steven Sell,
CEO & President -
Jeffrey A. Schwaneke,
Chief Financial Officer -
Diana Mckenzie,
Director -
Priscilla Kasenchak,
Chief Accounting Officer -
Timothy Gertsch,
Chief Accounting Officer